TRT(SH:600085) Ge Long Hui·2025-12-19 06:16Core Viewpoint - The investor research event held by Tongrentang Technology showcased the company's commitment to modernizing traditional Chinese medicine while maintaining its heritage and quality standards [1][3]. Group 1: Production and Technology - The production line at Tongrentang Technology employs automated and connected processes, ensuring a standardized, controllable, and efficient production of traditional Chinese medicine products [3]. - The company is actively investing in new equipment and technologies to build a modern intelligent manufacturing system for traditional Chinese medicine, aiming for high-quality, traceable products [3]. Group 2: Management Communication - During the event, the management team, led by General Manager Zhang Chunyou, engaged in in-depth discussions with investors regarding the company's strategic direction, core product layout, capacity enhancement, and future growth opportunities [4]. - The management emphasized the systemic development opportunities in the traditional Chinese medicine industry, driven by national health strategies and policies, and the company's commitment to deepening its presence in this field [4]. Group 3: Investor Relations - The event served as a platform for investor relations management, highlighting the importance of transparent and proactive communication between the company and its investors [5]. - Tongrentang Technology aims to create an open and inclusive investor relations ecosystem, reflecting its strategic determination and commitment to product value [5].